Statistics
Publications
5
Citations
3.1K
H-Index
5
Active since
2020
Eduardo Yañez is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, pembrolizumab therapy, and chemotherapy.
Publications per year
2020–2023
5
5
Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.8K citations · Full text
Medicine, Oncology, Pharmacology +16
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Nicoletta Colombo, Coraline Dubot, Domenica Lorusso et al. · New England Journal of Medicine · 2021 · 992 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Bradley J. Monk, Nicoletta Colombo, Krishnansu S. Tewari et al. · Journal of Clinical Oncology · 2023 · 236 citations
Medicine, Oncology, Pharmacotherapy +16
Bradley J. Monk, Krishnansu S. Tewari, Coraline Dubot et al. · The Lancet Oncology · 2023 · 70 citations · Full text
Medicine, Oncology, Pharmacotherapy +11
1–5 of 5